Business Description
Founded in 2000 and headquartered in Numazu, Japan, CanBas Co. Ltd. is a drug development company focused entirely on finding new ways to treat cancer. The company is currently testing two experimental treatments in human trials: CBP501, which works by targeting a specific protein involved in cell regulation, and CBS9106, which is being evaluated in patients with hard-to-treat solid tumors.
